A Conversation on the Medical Innovation Bill with Prof. José Miola and Prof. Dean Fennell

Series Name School of Law
Speaker Prof. José Miola and Prof. Dean Fennell
Type Lectures & Talks
Starts at Dec 03, 2014 05:30 PM
Ends at Dec 03, 2014 06:30 PM
Venue Ken Edwards LT 1
Open To University staff and students
Ticket Price Free
For Bookings Contact gemma.turton@le.ac.uk

To be given by Prof. José Miola (Law) and Prof. Dean Fennell (Cancer Studies and Molecular Medicine) on Wednesday 3rd December 5.30pm in Ken Edwards LT 1.

The Saatchi Bill claims that it will help doctors to innovate new treatments and cures, safely and responsibly, for cancer and other diseases. This event brings together the experts from law and medicine to discuss how this aim might be achieved and whether the Saatchi Bill will facilitate innovation without jeopardising patient safety.

Professor Fennell's clinical specialisation is in thoracic medical oncology and early clinical trials, particularly mesothelioma. Prof Fennell leads a Cancer Research UK funded group with a laboratory focusing on apoptosis, drug resistance, and signature-based therapeutics using the connectivity map for accelerated, targeted drug discovery. He is currently leading UK and international clinical trials of novel targeted therapies in Lung Cancer and Mesothelioma.

He has spoken in the House of Lords in support of the Saatchi Bill.

Professor Miola’s research interest is in medical law and ethics. José is Assistant Editor of the Medical Law Review and a member of the Editorial Board of the journal Clinical Ethics and the UK Clinical Ethics Network. His article, “Bye Bye Bolam: A Medical Litigation Revolution”, was cited by the High Court of Australia in the case of Rosenberg v. Percival [2001] HCA 18.

He has written numerous pieces for the ‘Stop the Saatchi Bill’ campaign and was quoted in the Government response to the consultation on the Bill.